XJPX
2503
Market cap13bUSD
Oct 09, Last price
2,800.00JPY
1D
1.80%
1Q
-1.30%
Jan 2017
47.25%
Name
Kirin Holdings Co Ltd
Chart & performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Kirin Holdings Company, Limited, a diversified global conglomerate, was established in 1885 and maintains its headquarters in Tokyo, Japan. This entity operates across Japan and internationally, manufacturing and marketing a broad array of products. Its core activities are structured around four key divisions: Japan Beer and Spirits, Japan Non-Alcoholic Beverages, Oceania Integrated Beverages, and Pharmaceuticals. Kirin's extensive product portfolio encompasses alcoholic beverages such as beer (including happo-shu), wine, whiskey, and spirits, alongside soft drinks, dairy items, and fruit juices. Beyond beverages, the company is a developer and purveyor of pharmaceutical and biochemical goods. Its operations extend to managing various factories and theme parks, overseeing a chain of Kirin City beer pubs, and manufacturing specialized amino acids and nucleic acids for both pharmaceutical and industrial applications, including bulk pharmaceuticals. Additionally, Kirin crafts items such as margarine, jams, and honey. The company is also involved in the production and distribution of Coca-Cola products, other soft drinks, sake, and various food items. Furthermore, it manufactures and supplies Four Roses bourbon and functions as an insurance agency. Kirin Holdings underwent a name change in July 2007, having previously been recognized as Kirin Brewery Company, Limited.
Related entities
Subsidiaries (6)
Kirin Brewery Company, Limited
Kirin Holdings Singapore Pte. Ltd.
LION PTY LTD
Mercian Corporation
Key people
Yoshinori Isozaki
Chairman of the Board, Chief Executive Officer, Representative Director · since 2024
Takeshi Minakata
President, Chief Operating Officer, Representative Director · since 2024
Junko Tsuboi
Vice President, Chief People Officer, Director · since 2024
Shinjiro Akieda
Managing Executive Officer, Director · since 2024
Hiroshi Fujikawa
Managing Executive Officer, Chief Director of R&D · since 2025
Managing Executive Officer, Chief Director of R&D · since 2025
Koji Fukada
Managing Executive Officer, President of Subsidiary · since 2024
Toshihito Hama
Managing Executive Officer · since 2025
Hideki Horiguchi
Managing Executive Officer, President of Subsidiary · since 2019
Kazuhiro Inoue
Managing Executive Officer, President of Subsidiary · since 2024
Akiyoshi Iwasaki
Managing Executive Officer · since 2024
Hideki Mitsuhashi
Managing Executive Officer, President of Subsidiary · since 2024
Kazufumi Nagashima
Managing Executive Officer, Director of Quality Assurance · since 2024
Mitsuharu Yamagata
Managing Executive Officer · since 2024
Toru Yoshimura
Managing Executive Officer, Chief Director of Health Science Business, Director · since 2024
Yoshiko Ando
Independent Director · since 2024
Independent Director · since 2020
Independent Director · since 2023
Independent Director · since 2025
Independent Director · since 2025
Headquarters & legal address
中野四丁目10番2号
東京都 中野区 164-0001
JP
東京都 中野区 164-0001
JP
Address
4-10-2,Nakano
Nakano-ku Tokyo 164-0001
JP
Nakano-ku Tokyo 164-0001
JP
Other language
Kirin Holdings Company, Limited
Valuation
Title JPY in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||